Clinical Trial Update: Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial assessing effects of NMRA-335140 in participants with Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NMRA-335140

Snippet

Sponsor: Neumora Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED